Skip Navigation

Office of Research Integrity

Institutional Biosafety Committee (IBC)


If you are a faculty member at MUSC, then please:

  1. read this important memo from the Interim Associate Provost for Research.
  2. complete the IBC attestation statement by clicking the hyperlink embedded in said memo. Deadline to complete the attestation statement is October 31, 2014This should take less than 2 minutes of your time.


The Medical University of South Carolina (MUSC) Institutional Biosafety Committee (IBC) and the Department of University Risk Management are closely aligned in a partnership to administer the MUSC Biosafety Program, which aims to minimize risks to MUSC and surrounding community from activities involving recombinant DNA, mircoorganisms, and biological toxins.

The MUSC IBC, under its Policies and Procedures and the NIH Guidelines for Reseach Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), oversees all research at MUSC using recombinant DNA [rDNA], microbes [of all risk groups, RG 1-4], and biotoxins.  Work with all Select Agents is included, requiring IBC approval before shipping to campus. Additional guidelines are provided by the Center for Disease Control (CDC) in their Biosafety in Microbiological and Biomedical Laboratories handbook.  

If you have any questions, please contact:

Dr. Yashmin Karten, IBC Administrator ( or 792-6512)

Dr. Dan Eisenman, Biosafety Officer ( or 792-4304)